24 HR Nifedipine 90 MG Extended Release Oral Tablet

INDICATIONS AND USAGE Nifedipine extended-release tablets, USP are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

ingenus pharmaceuticals, llc

FDA Reported Adverse Reactions
`[1] dyspnoea` `[2] drug ineffective` `[3] fatigue` `[4] nausea` `[5] diarrhoea` `[6] headache` `[7] off label use` `[8] pain` `[9] pneumonia` `[10] dizziness`

4 years ago

ROUND BROWN Novast 39

HOW SUPPLIED

NIFEDIPINE extended-release tablets, USP are supplied as 30 mg, 60 mg, and 90 mg round film coated tablets. The different strengths can be identified as follows:

NIFEDIPINE extended-release tablets, USP are supplied in the following bottle configurations: The tablets should be protected from light and moisture and stored at 20°-25°C (68°-77°F); [See USP Controlled Room Temperature]. Dispense in tight, light-resistant containers. image4 image5 image6

More pills like ROUND Novast 39

Related Pills

nifedipine tablet extended release

ingenus pharmaceuticals, llc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site